Algix; Arcoxia; Etoricoxibe; Nucoxia; Tauxib; L791456; MK 0663; MK 663; Algix (TN); Arcoxia (TN); L-791456; MK-0663; MK-663; Merck Sharp & Dohme brand of etoricoxib; Tauxib (TN); Etoricoxib (USAN/INN); Etoricoxib [USAN:INN:BAN]; 5-Chloro-6'-methyl-3-(p-(methylsulfonyl)phenyl)-2,3'-bipyridine; 5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine; 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine; 5CH

etoposide; 33419-42-0; VePesid; Toposar; trans-Etoposide; Lastet; (-)-Etoposide; Zuyeyidal; Etoposidum; Etoposido; Vepesid J; Eposin; Etoposidum [INN-Latin]; Etoposide (VP16); VP 16-213; VP 16 (pharmaceutical); Etoposido [INN-Spanish]; Etopophos (phosphate salt); VP-16-213; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; VP 16213; UNII-6PLQ3CP4P3; NK 171; NSC 141540; CCRIS 2392; HSDB 6517; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); EINECS 251-509-1; NSC-141540; Eposide; Etopol; Etosid; Vepeside; Demethyl EpipodophyllotoxinEthylidine Glucoside; E0675; Demethyl-epiodophyllotoxin ethylidene glucoside; Epipodophyllotoxin VP-16213; Eposin (TN); Etopophos (TN); Trans-Etoposide; VePESID (TN); Vepesid (TN); DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE; VP-16 (TN); Demethylepipodophyllotoxin-beta-D-ethylideneglucoside; Etoposide (JP15/USP/INN); Etoposide [USAN:INN:BAN:JAN]; Eposin, Vepesid, VP-16, Toposar, Etoposide; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin ethylidene-beta-D-glucoside; 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin; 4-Demethylepipodophyllotoxin-beta-D-ethylideneglucoside

RGV; MK 0518; Isentress(TM); K-0518; MK-0518; Raltegravir (INN); N-(2-(4-(4-fluorobenzylcarbamoyl); N-((4-Fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-4-pyrimidinecarboxamide; RAL

Beatrolol; BelocDuriles; Betaloc; BetalocAstra; Betalok; Dutoprol; LOPRESSIDONE; Lopresor; Lopresoretic; Lopressor; Meijoprolol; Metohexal; Metoprololum; Metroprolol; Preblok; Presolol; Seloken; Seroken; Spesicor; Spesikor; Toprol; AstraZeneca Brand of Metaoprolol Tartrate; AstraZeneca Brand of Seloken; Beloc Duriles; Betaloc Astra; Leiras Brand of Metoprolol Succinate or Metoprolol Tartrate; Metoprolol succinate; Novartis Brand of Metprolol Tartrate; Seloken AstraZeneca Brand; CGP 2175; CGP2175; H 93 26; H 9326; Beloc-Duriles; Betaloc (TN); Betaloc-Astra; CGP-2175; Corvitol (TN); Dl-Metoprolol; H 93-26; Lopressor (TN); Metoprololum [INN-Latin]; Metrol (TN); Minax (TN); Neobloc (TN); Selo-Zok; Selokeen (TN); TOPROL-XL; Tartrate, Metoprolol; Metoprolol (USAN/INN); Metoprolol [USAN:INN:BAN]; Toprol-XL (TN); (RS)-Metoprolol; 1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol; 1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol; 1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol; 1-[(1-methylethyl)amino]-3-({4-[2-(methyloxy)ethyl]phenyl}oxy)propan-2-ol; 1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol; 1-[4-(2-methoxyethyl)phenoxy]-3-propan-2-ylamino-propan-2-ol; 3-[4-(2-methoxyethyl)phenoxy]-1-(propan-2-ylamino)propan-2-ol

Onglyza; BMS 477118-11; BMS-477118; Kombiglyze XR (TN); OPC-262; Onglyza (TN); BMS-477118-11; (1S,5S)-2-[2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3

Kinzal; Kinzalmono; Micardis; Pritor; Abbott brand of telmisartan; Boehringer Ingelheim brand of telmisartan; Glaxo Wellcome brand of telmisartan; GlaxoSmithKline brand of telmisartan; BIBR 277; BIBR 277SE; BIBR-277; BIBR-277SE; Bay 68-9291; Micardis (TN); Telmisartan [USAN:INN]; YM-086; BIBR-277-SE; Telmisartan (JAN/USAN/INN); Micardis, Targit, Temax, BIBR277, Telmisartan; 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid; 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid; 4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid; 4'-((4-mehtyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimmidazolyl)methyl)-2-biphenylcarboxylic acid; 4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid; 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid; 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid

Baccidal; Barazan; Chibroxin; Fulgram; Lexinor; NFLX; Norflo; Norfloxacine; Norfloxacino; Norfloxacinum; Noroxin; Sebercim; Merck Brand of Norfloxacin; Norfloxacin Merck Brand; AM 0715; AM 715; AM0715; MK 0366; MK 366; MK0366; MK366; AM-0715; AM-715; Chibroxin (TN); Insensye (TN); MK-0366; MK-366; Norflohexal (TN); Norfloxacine [INN-French]; Norfloxacino [INN-Spanish]; Norfloxacinum [INN-Latin]; Norfocin (TN); Noroxin (TN); Nufloxib (TN); Roxin (TN); Utin (TN); Utinor (TN); Apo-Norflox (TN); Norfloxacin (JP15/USP/INN); Norfloxacin [USAN:BAN:INN:JAN]; Chibroxin, MK-366, Baccidal, Sebercim, Zoroxin, Norfloxacin; 1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-Ethyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeure; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-3-quinoline-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid

901119-35-5; R788; Tavalisse; UNII-SQ8A3S5101; R-788 Free acid; R 788; R-788; R-935788 Free acid; SQ8A3S5101; R7935788; Fostamatinib [USAN:INN]

Avinza; Kadian; Morphine Sulfate; Depodur; Astramorph Pf; Duramorph Pf; Infumorph; Ms Contin; Oramorph Sr

Tasocitinib; 477600-75-2; 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile; CP-690550; CP 690550; racemic-tofacitinib; 1259404-17-5; tofacitinibum; CP-690,550; UNII-87LA6FU830; 3-((3R,4R)-rel-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile; 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile; Tofacitinib (CP-690550,Tasocitinib); CHEMBL221959; CHEBI:71200; Xeljanz (TN)

1051375-16-6; GSK1349572; Tivicay; S/GSK1349572; Dolutegravir (GSK1349572); S-349572; GSK-1349572; GSK 1349572; UNII-DKO1W9H7M1; (4r,12as)-N-(2,4-Difluorobenzyl)-7-Hydroxy-4-Methyl-6,8-Dioxo-3,4,6,8,12,12a-Hexahydro-2h-Pyrido[1',2':4,5]pyrazino[2,1-B][1,3]oxazine-9-Carboxamide; CHEBI:76010; DKO1W9H7M1; Tivicay (TN); (4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide; Dolutegravir Sodium (

Donepezil (transdermal patch, Alzheimer's disease)

Elagolix sodium salt; UNII-5948VUI423; Elagolix sodium [USAN]; 5948VUI423; Elagolix sodium (USAN); SCHEMBL1641994; NBI 56418NA; NBI-56418-NA; MolPort-003-984-965; NBI-56418 NA; DQYGXRQUFSRDCH-UQIIZPHYSA-M; AKOS030524154; VA12044; KS-0000063K; KB-76766; HY-14369; AC-29671; CS-0003317; D09336

KCZ; KTZ; K 1003; R 41400; R41400; KS-1205; KW-1414; Perkhotal (TN); R 41,400; R-41400; R41,400; Ketoconazole [USAN:INN:BAN:JAN]; Nizoral, Extina, Xolegel, Kuric, Ketoconazole; Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-piperazine; Cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine; CIS-1-ACETYL-4-(4-((2-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)PIPERAZINE; (+-)-cis-1-Acetyl-4-(p-((2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine; (+/-)-cis-1-Acetyl-4-(4-[(2-[2,4-dichlorophenyl]-2-[1H-imidazol-1-ylmethyl]-1,3-dioxolan-4-yl)-methoxy]phenyl)piperazine; (+/-)-cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine; 1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone; 1-acetyl-4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine

Acalix; Adizem; Aldizem; Anoheal; Cardil; Cardizem; Citizem; Dilacor; Dilcontin; Dilren; Diltia; Diltiazemum; Dilticard; Diltzac; Dilzen; Endrydil; Viazem; Cardizen LA; Incoril AP; Tiazac Tildiem; Tiazac XC; Adizem (TN); Altiazem (TN); Angiozem (TN); Angizem (TN); Angizem CD (TN); Apo-Diltiaz; Cardizem (Hydrochloride); Cardizem (TN); Cartia XT (TN); Dilacor-XR; Dilatam (TN); Dilatem (TN); Dilcardia (TN); Dilcontin SR (TN); Dilt-cd; Dilta-Hexal; Diltelan (TN); Diltiazem (INN); Diltiazem [INN:BAN]; Diltiazemum [INN-Latin]; Diltime (TN); Dilzem (TN); Dyalec (TN); Filazem (TN); Herben (TN); Nu-Diltiaz; Progor (TN); RG 83606 (Hydrochloride); Surazem (TN); Tiamate (TN); Tiazac (TN); Tiazac XC (TN); Tildiem (TN); Vasmulax (TN); Viazem (TN); Zandil (TN); Zemtrial (TN); D-cis-Diltiazem; MK-793 (Malate); [(2S,3S)-5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate; Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester; (+)-cis-5-[2-(dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester; (2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate; (2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate; (2S,3S)-5-[2-(dimethylamino)ethyl]-2-[4-(methyloxy)phenyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate; (2S-cis)-3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one

LESINURAD; 878672-00-5; RDEA594; Zurampic; RDEA 594; UNII-09ERP08I3W; RDEA-594; 2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid; 09ERP08I3W; AK323774; C17H14BrN3O2S; 2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetic acid; 2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid; 2-(5-Bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid

Arpamyl; Calan; Calcan; Cordilox; Dexverapamil; Dilacoran; Drosteakard; Iproveratril; Isoptimo; Isoptin; Isotopin; Vasolan; Veracim; Verapamilo; Verapamilum; Veraptin; Verexamil; Bosoptin (TN); Calan (TN); D-365; Isoptin (TN); Verapamilo [INN-Spanish]; Verapamilum [INN-Latin]; Verelan (TN); CP-16533-1; Covera-HS (TN); Verapamil (USAN/INN); Verapamil [USAN:BAN:INN]; Verapamil [USAN:INN:BAN]; Alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile; (+-)-Verapamil; (+/-)-VERAPAMIL; (1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile; 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile; 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile; 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; Verapamil (Na-Ca chanel blocker)

Losec (TN)

Voxelotor; Hemoglobin Modulators-1; 1446321-46-5; UNII-3ZO554A4Q8; GBT 440; 3ZO554A4Q8; 2-hydroxy-6-([2-[1-(propan-2-yl)-1H-pyrazol-5-yl]pyridin-3-yl]methoxy)benzaldehyde; 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde; 2-hydroxy-6-((2-(1-(propan-2-yl)-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde; Voxelotor [USAN]; SCHEMBL15065529; Voxelotor(GBT440, GTx011); GTX-011; GBT-440; MolPort-044-830-677; FWCVZAQENIZVMY-UHFFFAOYSA-N; AKOS030526545; ZINC145969085; CS-5317; HY-18681; DA-44587; S

Cognex; Romotal; Tacrina; Tacrinal; Tacrinum; Tenakrin; Tetrahydroaminacrine; Tetrahydroaminoacridine; Tetrahydroaminocrin; Tetrahydroaminocrine; Tha; Tacrine hydrochloride; BBL001044; CS 12602; Cognex (TN); Tacrina [INN-Spanish]; Tacrinal (TN); Tacrine (INN); Tacrine [INN:BAN]; Tacrinum [INN-Latin]; 1,2,3,4-TETRAHYDRO-9-ACRIDINAMINE; 1,2,3,4-TETRAHYDRO-9-ACRIDINAMINE (SEE ALSO 1684-40-8); 1,2,3,4-Tetrahydro-9-acridineamine; 1,2,3,4-Tetrahydro-acridin-9-ylamine; 1,2,3,4-Tetrahydroaminoacridine; 1,2,3,4-tetrahydroacridin-9-amine; 5-Amino-6,7,8,9-tetrahydroacridine (European); 9-AMINOTETRAHYDROACRIDINE; 9-Acridinamine, 1,2,3,4-tetrahydro-(9CI); 9-Amino-1,2,3,4-Tetrahydroacridine Hydrate Hydrochloride Hydrate; 9-amino-1,2,3,4-tetrahydroacridine

BENZNIDAZOLE; Radanil; Benzonidazole; 22994-85-0; Benznidazol; benzonidazol; Benznidazolum;Ro 07-1051; Rochagan; UNII-YC42NRJ1ZD; Benznidazolum [INN-Latin]; Benznidazol [INN-Spanish]; Ro 71051; NSC 299972; Benznidazole [INN]; CCRIS 2200

HDPC; HePC; Hexadecylphosphocholine; Hexadecylphosphorylcholine; Impavido; Miltefosina; Miltefosinum; Miltex; Baxter Oncology brand of miltefosine; Baxter brand of miltefosine; Miltefosin C; Prasfarma brand of miltefosine; D 18506; IN1227; D-18506; H-1850; M-7200; Miltefosina [INN-Spanish]; Miltefosine (INN); Miltefosine[INN:BAN]; Miltefosinum [INN-Latin]; N-Hexadecylphosphorylcholine; TF-002; Choline hydroxide, hexadecyl hydrogen phosphate, inner salt; Choline, hexadecyl hydrogen phosphate, inner salt; Hexadecyl 2-(trimethylazaniumyl)ethyl phosphate; Choline phosphate, hexadecyl ester, hydroxide, inner salt; Choline phosphate, hexadecyl ester, hydroxide, inner salt (6CI); Hexadecyl 2-(trimethyl-.lambda.~5~-azanyl)ethyl hydrogen phosphate; Ethanaminium, 2-(((hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, inner salt; Ethanaminium, 2-(((hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, innner salt; 1-Hexadecylphosphorylcholine; 2-(((Hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethylethanaminium hydroxide, inner salt; 3,5-Dioxa-4-phosphaunacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide

Lomidine; Nebupent; PENTAM; PNT; Pentacarinat; Pentamide; Pentamidin; Pentamidina; Pentamidinum; Pneumopent; PENTAMIDINE ISETHIONATE; Pentamidina [DCIT]; Pentamidine isetionate; Pentamidine mesylate; MB 800; Pentam 300; Lomidine (TN); MB-800; Nebupent (as isethionate); Pentacarinat (as isethionate); Pentam 300 (as isethionate); Pentamidine (INN); Pentamidinum [INN-Latin]; RP-2512; Nebupent (*Isethionate); Pentacarinat (*Isethionate); Pentam 300 (*Isethionate); Pentamidine Isethionate 2-Hydroxy-Ethanesulfonic Acid;Pentamidine [INN:BAN:DCF]; RP 2512 (*Isethionate); P,p'-(Pentamethylenedioxy)bis[benzamidine]; P,p'-(Pentamethylenedioxy)dibenzamidine; P,p'-(Pentamethylene-dioxy)bis-benzamidine; Benzenecarboximidamide, 4,4'-(1,5-pentanediylbis(oxy))bis-(9CI); 1,3-BIS(4-AMIDINOPHENOXY)PENTANE; 4, 4'-Diamidinodiphenoxypentane; 4,4'-(1,5-Pentanediylbis(oxy))bis-benzenecarboximidamide; 4,4'-(Pentamethylenedioxy)dibenzamide; 4,4'-(Pentamethylenedioxy)dibenzamidine; 4,4'-Diamidino-.alpha.,.omega.-diphenoxypentane; 4,4'-Diamidinodiphenoxypentane; 4,4'-[pentane-1,5-diylbis(oxy)]dibenzenecarboximidamide; 4-[5-(4-Carbamimidoylphenoxy)pentoxy]benzenecarboximidamide

BETA-SITOSTEROL; Sitosterol; 83-46-5; Cupreol; Quebrachol; 22,23-Dihydrostigmasterol; Triastonal; Azuprostat; Rhamnol; Cinchol; Harzol; beta-Sitosterin; alpha-Dihydrofucosterol; Nimbosterol; Stigmast-5-en-3beta-ol; B-Sitosterol; Sito-Lande; (-)-beta-Sitosterol; (3beta)-Stigmast-5-en-3-ol; .beta.-Sitosterol; Angelicin (steroid); 24alpha-Ethylcholesterol; a-Dihydrofucosterol; .beta.-Sitosterin; Phytosterol; Prostasal; NSC8096; SITOSTEROL, BETA; (24R)-Stigmast-5-en-3beta-ol; .alpha.-Dihydrofucosterol; (24R)-Ethylcholest-5-en-3beta-ol

HYDRASTINE; 118-08-1; beta-Hydrastine; l-Hydrastine; (-)-Hydrastine; CHEBI:69919; A-Hydrastine; UNII-8890V3217X; EINECS 204-233-0; BRN 0098575; HYDRASTINE (1R, 9S); (1R,9S)-(-)-beta-Hydrastine; 8890V3217X; Phthalide, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-; 6,7-Dimethoxy-3-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinoline-5-yl)-1(3H)-isobenzo furan; 3-((5R)-6-methyl(5,6,7,8-tetrahydro-2H-1,3-dioxoleno[4,5-g]isoquinolin-5-yl))( 3S)-6,7-dimethoxy-3-hydroisobenzofuran-

Abboticin; Abomacetin; Acneryne; Acnesol; Aknemycin; Aknin; AustriaS; Benzamycin; Derimer; Deripil; Dotycin; Dumotrycin; ERY; ERYC; Emgel; Emuvin; Emycin; Endoeritrin; Erecin; Erisone; Eritomicina; Eritrocina; Eritromicina; Ermycin; Eros; Eryacne; Eryacnen; Erycen; Erycette; Erycin; Erycinum; Eryderm; Erydermer; Erygel; Eryhexal; Erymax; Erymed; Erysafe; Erytab; Erythro; Erythroderm; Erythrogran; Erythroguent; Erythromid; Erythromycine; Erythromycinum; Erytop; Erytrociclin; Ilocaps; Iloticina; Ilotycin; Inderm; IndermRetcin; Latotryd; Lederpax; Mephamycin; Mercina; Oftamolets; Paediathrocin; Pantoderm; Pantodrin; Pantomicina; Pharyngocin; Primacine; Propiocine; Proterytrin; Retcin; Robimycin; Romycin; Sansac; Staticin; Stiemicyn; Stiemycin; Tiloryth; Tiprocin; Torlamicina; Wemid; Akne Cordes Losung; Aknederm Ery Gel; Benzamycin Pak; ERYTHROMYCIN STEARATE; Eryc Sprinkles; Erythromycin A; Erythromycin Lactate; Erythromycin Ointment; Erythromycin base; Erythromycin intravenous; Erythromycin sodium lauryl sulfate; Inderm Gel; Oftalmolosa Cusi Eritromicina; Skid Gel E; Theramycin Z; Udima Ery Gel; E0751; Eryc 125; Erythromast 36; Ak-Mycin; Akne-Mycin; Del-Mycin; E-Base; E-Glades; E-Mycin; E-Solve 2; ERYC (base); Emu-V; Emu-Ve; Erimycin-T; Eritromicina [INN-Spanish]; Ery-B; Ery-Diolan; Ery-Sol; Ery-Tab; Ery-maxin; Eryc (TN); Eryc-125; Eryc-250; Erygel (TN); Erythra-Derm; Erythro-Statin; Erythro-Teva; Erythromycin & VRC3375; Erythromycine [INN-French]; Erythromycinum [INN-Latin]; Ilosone (TN); Ilosone (estolate); Ilotycin T.S; Kesso-Mycin; N-Methylerythromycin A; PCE Dispertab (base); Pce (TN); R-P Mycin; Sans-acne; Staticin (TN); T-Stat; Taimoxin-F; A/T/S; Akne-mycin (TN); C-Solve-2; E-Base (base); E-Mycin (base); Ery-Tab (base); Erythromycin [INN:BAN:JAN]; Ilotycin T.S.; T-stat (TN); E-mycin, Erycin, Robimysin; Erythromycin (JP15/USP/INN); Erythromycin, compd. with monododecyl sulfate, sodium salt; Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin; Adecane-2,10-dione (non-preferred name); Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279; Ery

ACT-129968

NPI-2358

820957-38-8; UNII-GIE06H28OX; GSK221149A; GSK-221149A; GIE06H28OX; CHEMBL429736; Retosiban [USAN:INN]; Retosiban (USAN); GSK 221149A; SCHEMBL230301; GTPL8403; DTXSID00231559; PLVGDGRBPMVYPB-FDUHJNRSSA-N; ZINC6718496; BDBM50372608; GSK-221,149-A; SB16762; DB11818; HY-14778; CS-0003555; J3.542.064I; D08986; 2,5-Piperazinedione, 3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-4-oxazolyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-, (3R,6R)-

SCH-900271; UNII-G2283XQ6VJ; SCH 900271; G2283XQ6VJ; 915210-50-3; CHEMBL2036958; GTPL8469; SCHEMBL12602910; DTXSID00238609; BDBM50384612; SCH900271; SB17408; DB12433; 2H-Pyrano(2,3-d)pyrimidine-2,4,7(1H,3h)-trione, 5-(3-(1-methylcyclopropyl)propyl)-; 5-(3-(1-Methylcyclopropyl)propyl)-1H-pyrano(2,3-d)pyrimidine-2,4,7(3H)-trione

ONBSHRSJOPSEGS-INIZCTEOSA-N; PT-2385; UNII-6O16716DXP; 1672665-49-4; 6O16716DXP; SCHEMBL16555810; ZINC230453533; AKOS030526641; HY-12867; PT2385,1672665-49-4, PT 2385,PT-2385; Benzonitrile, 3-(((1S)-2,2-difluoro-2,3-dihydro-1-hydroxy-7-(methylsulfonyl)-1H-inden-4-yl)oxy)-5-fluoro-; 3-{[(1s)-2,2-Difluoro-1-Hydroxy-7-(Methylsulfonyl)-2,3-Dihydro-1h-Inden-4-Yl]oxy}-5-Fluorobenzonitrile; 3-(((1S)-2,2-Difluoro-1-hydroxy-7-methanesulfonyl-2,3-dihydro-1hinden-4-yl)oxy)-5-fluorobenzonitrile; 79A

vamorolone; Vamorolone; 13209-41-1; UNII-8XP29XMB43; VBP-15; 8XP29XMB43; CHEMBL2348780; 17,21-Dihydroxy-16alpha-methylpregna-1,4,9(11)-triene-3,20-dione; A-Methyl-9,11-dehydro Prednisolone; (8S,10S,13S,14S,16R,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one; Vamorolone [USAN]; VBP-15 free alcohol; VBP 15; EINECS 236-177-8; AC1MHYKY; Vamorolone (USAN/INN); SCHEMBL143459; GTPL9247; A)-17,21-dihydroxy-16-methylpregna-1,4,9(11)-triene-3,20-dione; ZINC33650317

Olorinab; UNII-581F7DFA9B; 581F7DFA9B; Olorinab [USAN]; SCHEMBL11995430; 1268881-20-4; (4aS,5aS)-N-((2S)-1-hydroxy-3,3-dimethylbutan-2-yl)-1-(4-oxidopyrazin-2-yl)-4,4a,5,5a-tetrahydro-1H-cyclopropa(4,5)cyclopenta(1,2-c)pyrazole-3-carboxamide; 1H-Cyclopropa(4,5)cyclopenta(1,2-c)pyrazole-3-carboxamide, 4,4a,5,5a-tetrahydro-N-((1S)-1-(hydroxymethyl)-2,2-dimethylpropyl)-1-(4-oxido-2-pyrazinyl)-, (4aS,5aS)-; (1aS,5aS)-2-(4-Oxy-pyrazin-2-yl)-1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclopropa(a)pentalene-4-carboxylic aci

UNII-CQY12ZJN6E; CQY12ZJN6E; 1187856-49-0; Ralinepag [USAN:INN]; Ralinepag (USAN/INN); SCHEMBL1118504; SCHEMBL1118506; SCHEMBL12786473; CHEMBL3919269; CHEMBL3301604; AKOS027337124; DB12462; 2-((trans-4-((((4-Chlorophenyl)(phenyl)carbamoyl)oxy)methyl)cyclohexyl)methoxy)acetic acid; Acetic acid, 2-((trans-4-(((((4-chlorophenyl)phenylamino)carbonyl)oxy)methyl)cyclohexyl)methoxy)-; HY-16751; CS-0012350; J3.614.088G; D10725

Picovir; Pleconaril < Prop INN; SR-263843; SR-63843; VP-63843; Win-63843; 3-[3,5-Dimethyl-4-[3-(3-methylisoxazol-5-yl)propoxy]phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole

SCY-635; CHEMBL1269597; UNII-WSU5343074; WSU5343074; SCY 635; CID6479267; AC1O57KA; 210759-10-7; BDBM50136473; DB12451; (3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-27-(2-dimethylaminoethylsulfanyl)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-24-(2-hydroxy-2-methylpropyl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone

962040

Small molecule, JAK1/JAK2 inhibitor (rheumatoid arthritis), Galapagos/GSK

Telacebec; 1334719-95-7; UNII-55G92WGH3X; 55G92WGH3X; Q-203; CHEMBL3298910; SCHEMBL12295312; MMV687696; BDBM50022086; ZINC169325657; CS-6412; Imidazo(1,2-a)pyridine-3-carboxamide, 6-chloro-2-ethyl-N-((4-(4-(4-(trifluoromethoxy)phenyl)-1-piperidinyl)phenyl)methyl)-; AS-35270; HY-101040; Q 203; EN300-218150; Z2235679010; 6-chloro-2-ethyl-N-[(4-{4-[4-(trifluoromethoxy)phenyl]piperidin-1-yl}phenyl)methyl]imidazo[1,2-a]pyridine-3-carboxamide; 6-chloro-2-ethyl-N-[[4-[4-[4-(trifluoromethoxy)phenyl]-1-piperidyl]phenyl]methyl]im

Epelsiban; Epelsiban besylate; Premature ejaculation therapeutic (oral), GlaxoSmithKline

GHTGYZMBQPXTCQ-UHFFFAOYSA-N; GLPG1837; 1654725-02-6; SCHEMBL16444982; GLPG 1837; EX-A1819; BCP23611; GLPG-1837(ABBV-974); HY-111099; CS-0034220; N-(3-carbamoyl-5,5,7,7-tetramethyl-4,7-dihydro-5H-thieno[2,3-c]pyran-2-yl)-1H-pyrazole-3-carboxamide

GW842166X; 666260-75-9; GW 842166X; GW-842166X; UNII-VL1I6P2DZ8; VL1I6P2DZ8; GW842166; GW 842166; CHEMBL225411; 2-((2,4-dichlorophenyl)amino)-N-((tetrahydro-2H-pyran-4-yl)methyl)-4-(trifluoromethyl)pyrimidine-5-carboxamide; TWQYWUXBZHPIIV-UHFFFAOYSA-N; 842166X; MLS006010287; C18H17Cl2F3N4O2; SCHEMBL3015040; DTXSID60216786; MolPort-009-019-316; HMS3656P06; BCP05306; ZINC3947932; BDBM50211843; s2778; 2455AH; AKOS032945128; DB11903; BCP9000755; CS-7768; SB19546; API0013938; GW-842,166X; NCGC00346697-05; NCGC00346697-01; KB-77649; HY-14167

Metapro; 6-O-[N-[1(R)-Carbamoyl-2-methylpropyl]carbamoyl]fumagillol

ISOQUINE; CHEMBL147587; NINDS_000687; Spectrum_000046; Spectrum4_000147; Spectrum2_000768; Spectrum5_000808; Spectrum3_000299; AC1L1D2I; KBioSS_000426; BSPBio_001838; KBioGR_000594; DivK1c_000687; SPBio_000816; SCHEMBL5836418; KBio2_000426; KBio1_000687; KBio3_001338; KBio2_002994; CTK6E7963; KBio2_005562; ZINC36378506; BDBM50134931; IDI1_000687; NCGC00178968-01; SBI-0051280.P003; AB00053418_02; 5-(7-chloroquinolin-4-ylamino)-2-diethylaminomethylphenol; 5-[(7-chloroquinolin-4-yl)amino]-2-(diethylaminomethyl)phenol

3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione; 198474-05-4; PF06840003; 2,5-Pyrrolidinedione, 3-(5-fluoro-1H-indol-3-yl)-; 3-(5-fluoro-indol-3-yl)-pyrrolidine-2,5-dione; SCHEMBL5463464; GTPL9565; CTK0A0183; DTXSID00630149; MXKLDYKORJEOPR-UHFFFAOYSA-N; KS-000008MY; EX-A1186; EOS200271; AKOS027252536; CS-6186; AS-51973; HY-101111; 3-(5-Fluoro-1H-indol-3-yl)-pyrrolidine-2,5-dione

Mibefradil (Cytostatic Checkpoint Therapy, ovarian cancer); Mibefradil (Cytostatic Checkpoint Therapy, ovarian cancer), Tau Therapeutics; Calcium T-channel inhibitor (Cytostatic Checkpoint Therapy, ovarian cancer), Tau Therapeutics

PMID28067079-Compound-63

844903-58-8; GSK-163090; UNII-7XI927X82B; CHEMBL1631540; 7XI927X82B; 1-(3-(2-(4-(2-Methyl-5-quinolinyl)-1-piperazinyl)ethyl)phenyl)-2-imidazolidinone; 1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone; 1-[3-[2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl]phenyl]-2-imidazolidinone; ANGUXJDGJCHGOG-UHFFFAOYSA-N; GSK 163090; SCHEMBL2881345; DTXSID30233480; EX-A1027; BCP16941; ZINC34451922; BDBM50333015; AKOS030526918; CS-5315; HY-14348

Tariquidarth; XR 9576; XR9576; Tariquidar (USAN/INN); N-[2-[[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide; N-(2-((4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)carbamoyl)-4,5-dimethoxyphenyl)quinoline-3-carboxamide

CH-4987655; RO-04927350; MEK inhibitors (solid tumor), Roche

SB 206553; 158942-04-2; SB-206553; Tocris-1661; CHEMBL297784; CHEBI:8977; UNII-AL4387525T; AL4387525T; SB-206,553; 1-methyl-N-pyridin-3-yl-6,7-dihydropyrrolo[2,3-f]indole-5-carboxamide; SB-206553 hydrochloride hydrate; SB206553; Lopac-S-180; AC1L1JQU; AC1Q5NRE; Lopac0_001163; GTPL189; SCHEMBL1459242; ZINC5994; DTXSID9043984; CTK8H1211; BDBM50060417; pyrrolo[2,3-f]indole-1(2h)-carboxamide, 3,5-dihydro-5-methyl-n-3-pyridinyl-; AKOS027381420; 5-Methyl-N-(3-pyridinyl)-3,5-dihydropyrrolo[2,3-f]indole-1(2H)-carboxamide; CCG-205237

chrysin; 480-40-0; 5,7-Dihydroxyflavone; Chrysine; 5,7-Dihydroxy-2-phenyl-4H-chromen-4-one; Crysin; 5,7-dihydroxy-2-phenylchromen-4-one; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-phenyl-; UNII-3CN01F5ZJ5; NSC-407436; FLAVONE, 5,7-DIHYDROXY-; EINECS 207-549-7; NSC407436; 5,7-Dihydroxy-2-phenyl-4H-1-benzopyran-4-one; CHEMBL117; NSC 407436; 5,7-Dihydroxy-2-phenyl-chromen-4-one; BRN 0233276; 3CN01F5ZJ5; CHEBI:75095; RTIXKCRFFJGDFG-UHFFFAOYSA-N; 5,7-Dihydroxy-2-phenyl-4H-benzo(b)pyran-4-one; MFCD00006834; Chrysin, 99+%; CAS-480-40-0

PF-3246799; PHA-181731A; PHA-57378; PHA-670080; PNU-181731A; PNU-57378; PNU-57378E; 5-HT 2 agonists, Pharmacia

colchicine; 64-86-8; Colchicin; Colchicina; Colchisol; Condylon; Colcin; Colsaloid; Colchicinum; Colchineos; 7alphaH-Colchicine; Colcrys; (S)-colchicine; Colchicin [German]; spindle poison; Colchicina [Italian]; 7-alpha-H-Colchicine; NSC 757; UNII-SML2Y3J35T; N-Acetyl trimethylcolchicinic acid methylether; CCRIS 691; NSC757; HSDB 3044; EINECS 200-598-5; Colchicine

GTPL8175; BDBM50420996

Decadron; Dexamethazone; Maxidex; Prednisolone F; Decaspray; Desametasone; Hexadecadrol; Hexadrol; Dexasone; Oradexon; Dexacort; Deltafluorene; Superprednol; Visumetazone; Mediamethasone; Desamethasone; Dergramin; Mymethasone; Dinormon; Dexapolcort; Dexalona; Desameton; Desadrene; Cortisumman; Aphtasolon; Turbinaire; Dextelan; Dexameth; Decaderm; Millicorten; Gammacorten; Fortecortin; Dexadeltone; Dekacort; Dectancyl; Decasone; Dexason; Mexidex; Dexone; Calonat; Corsone; Auxiron; Fluormethylprednisolone; Azium; Dexa-Cortisyl

Cortisol; Acticort; Cetacort; Hydrasson; Hydrocortisyl; Cobadex; Hycort; Signef; Hytone; Cortef; 17-Hydroxycorticosterone; Optef

ADS-102550; CHEMBL217716; SCHEMBL5903759; BDBM50198218

desethyl isoquine; CHEMBL146826; ZINC1912679; BDBM50134934

4-Phenylimidazole; 670-95-1; 4-PHENYL-1H-IMIDAZOLE; 5-Phenyl-1H-imidazole; 4(5)-Phenylimidazole; 1H-Imidazole, 4-phenyl-; Imidazole, 4-phenyl-; 5-phenylimidazole; 4-PHENYL IMIDAZOLE; CHEMBL14145; XHLKOHSAWQPOFO-UHFFFAOYSA-N; MFCD00005197; NSC-195337; F1918-0054; PIM; 4-phenyl-1h-imidazol; 4-phenyl-imidazole; EINECS 211-580-1; PubChem7224; NSC 195337; ACMC-209nxp; 4-phenylimidazole, 4-PI; 4-Phenylimidazole, 97%; 1H-Imidazole, 5-phenyl-; AC1L2C7W; AC1Q4YD1; SCHEMBL37563; KSC696A2D; Imidazole, 4-phenyl- (8CI); AMBZ0133; CTK5J6021

(S)-1 [PMID: 16904708]; compound 2 [PMID: 12852750]

TG-100435; CHEMBL230686; SCHEMBL4266197; ZINC28702706; BDBM50198782; US8481536, 367; US8481536, 575; ([7-(2,6-dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine); 7-(2,6-dichlorophenyl)-5-methyl-N-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)benzo[e][1,2,4]triazin-3-amine

(5-phenylfuran-2-yl)methanamine; 39170-18-8; 2-Furanmethanamine, 5-phenyl-; 5-phenylfurfurylamine; AC1Q53ZI; SCHEMBL720013; (5-phenyl-2-furyl)methylamine; CHEMBL214859; CTK7E5186; BDBM12363; MolPort-004-306-048; 1-(5-phenyl-2-furyl)methanamine; ZINC14949858; nicotine 3-heteroaromatic analogue 22; AKOS000143046; MCULE-3484411839; AJ-65506; EN300-49879

[6]-Gingerol; 6-Gingerol

CHEMBL320105; 2-Hexyloxy-5-imidazol-1-yl-pyridine; SCHEMBL14129948; BDBM50138236

1-Benzylimidazole; 1-Benzyl-1H-imidazole; 4238-71-5; N-Benzylimidazole; Imidazole, 1-benzyl-; BENZYLIMIDAZOLE; 1H-Imidazole, 1-(phenylmethyl)-; 1-BENZYL IMIDAZOLE; CCRIS 5821; EINECS 224-200-4; 1-Benzylimidazole, 99%; NSC 217337; NSC 126828; CHEMBL14192; AI3-52572; MLS000069473; KKKDZZRICRFGSD-UHFFFAOYSA-N; MFCD00005296; SMR000059044; 1BN; 1-benzylimdazole; 2afx; 1-benzyl-imidazole; 3pb9; 1-Benzylimidazole (BI); Maybridge3_003880; Opera_ID_1637; SCHEMBL414; ACMC-209jp9; AC1Q28WR; AC1L2U3N; AC1Q4X5Z; AC1Q28WS; KSC492M7H; MLS001424205

RUTIN; 153-18-4; rutoside; Phytomelin; Quercetin 3-rutinoside; Birutan; Eldrin; Rutin trihydrate; Myrticolorin; Venoruton; Bioflavonoid; Paliuroside; Tanrutin; Osyritrin; Rutine; Rutozyd; 3-Rutinosyl quercetin; 3-Rhamnoglucosylquercetin; Quercetin 3-O-rutinoside; Rutosido; Rutosidum; Rutinum; Globularicitrin; Quercetin-3-rutinoside; Rutabion; Violaquercitrin; Globulariacitrin; Melin; Rutinic acid; Birutan Forte; Birutin; Quercetin rhamnoglucosine; Quercetin-3beta-rutinoside; UNII-5G06TVY3R7; Oxyritin; Rutosid; Ilixanthin; Rutinion acid

GW 848687X; GW-848687X

SB-242,084; SB242084

SB-243213; SB 243213; AC1L9EKT; UNII-R6MR8DB4PZ; R6MR8DB4PZ; CHEMBL14460; CHEBI:8980; sb 243213 dihydrochloride; 200940-22-3; 5-methyl-N-[6-(2-methylpyridin-3-yl)oxypyridin-3-yl]-6-(trifluoromethyl)-2,3-dihydroindole-1-carboxamide; 5-methyl-N-(6-((2-methylpyridin-3-yl)oxy)pyridin-3-yl)-6-(trifluoromethyl)indoline-1-carboxamide; 5-Methyl-N-(6-((2-methylpyridin-3-yl)oxy)pyridin-3-yl)-6-(trifluoromethyl)-2,3-dihydro-1H-indole-1-carboxamide

CHEMBL468927; BMS pyrazole inhibitor 7f; ASIS-P021; GTPL7030; SCHEMBL14565559; ZINC40891759; BDBM50258790; (2S)-2-amino-N-[(3-{5-[5-(1,3-benzothiazol-7-yl)-1,3,4-oxadiazol-2-yl]-3-(trifluoromethyl)-1H-pyrazol-1-yl}phenyl)methyl]propanamide; (S)-2-amino-N-(3-(5-(5-(benzo[d]thiazol-7-yl)-1,3,4-oxadiazol-2-yl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzyl)propanamide

SB-221284; SB221284

3-(1-methylpyrrolidin-2-yl)pyridine; 22083-74-5; Nikotin; (R,S)-Nicotine; Black Leaf 40; Pyridine, 3-(1-methyl-2-pyrrolidinyl)-; Black leaf; Nicotine alkaloid; Nicotin; Nicocide; Tendust; (RS)-Nicotine; Nico-dust; Emo-nik; Nico-Fume; Mach-Nic; Nic-Sal; Nicotina; Nikotyna; CHEMBL440464; (+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine; NSC5065; SNICXCGAKADSCV-UHFFFAOYSA-N; BRN 0082111; 3-(1-Methyl-2-pyrrolidinyl)pyridine

CHEMBL214335; 1-(2-(2-methoxyphenyl)-1-phenylethyl)piperazine; SCHEMBL5440547; BDBM50188048; (-)-1-(2-(2-methoxyphenyl)-1-phenylethyl)piperazine

CHEMBL3234858; SCHEMBL14873629; BDBM50009583

CHEMBL3427272; BDBM50088179

CHEMBL476763; SCHEMBL2010557; BDBM50263396; AKOS008854805; N-[2-[[(4-chlorophenyl)-phenylmethyl]amino]-2-oxoethyl]benzamide; rac-n-({[(4-chloro-phenyl)-phenyl-methyl]-carbamoyl}-methyl)-benzamide

CHEMBL3353862; SCHEMBL9893080; BDBM50042591

CHEMBL3806003

CHEMBL3929505; SCHEMBL17492299; BDBM254004; US9481673, (S)-14

CHEMBL4065956; SCHEMBL697856; BDBM50269415

CHEMBL1761535; BDBM50340419

CHEMBL1641811; SCHEMBL2214672; BDBM50333497

CHEMBL4091821; SCHEMBL15222561; BDBM50249403

CHEMBL2385906; SCHEMBL3071152; BDBM50434979; ZINC38266712

CHEMBL4065818; SCHEMBL696586; BDBM50269440; 2-[(2R)-4-(2-methoxyphenyl)-2-methylpiperazin-1-yl]-3-methyl-6-pyrimidin-4-ylpyrimidin-4-one

CHEMBL520237; SCHEMBL5131584

CHEMBL4077048; SCHEMBL696752; BDBM50269439

CHEMBL4065483; SCHEMBL18910111; BDBM50263635

CHEMBL3287188; SCHEMBL16989882; BDBM50019867

CHEMBL1808631; BDBM50349491

CHEMBL2348857; SCHEMBL14746554; SCHEMBL14746555; SCHEMBL14751548; SCHEMBL14751956; BDBM50431386

SCHEMBL1542369; CHEMBL2431457; N-[2-Methoxy-3-tert-butyl-5-(2-oxo-1,2-dihydropyridine-3-yl)phenyl]-4-(methylsulfonylamino)benzamide

CHEMBL3088176; BDBM50443001

CHEMBL515644; BDBM50263682; 4-Fluoro-N-{[(2-fluoro-6,11-dihydro-dibenzo[b,e]oxepin-11-ylmethyl)-carbamoyl]-methyl}-benzamide

CHEMBL487965; BDBM50275432

CHEMBL3969059; SCHEMBL17492290; BDBM254003; US9481673, (S)-13

CHEMBL4076060; SCHEMBL695349; BDBM50269438

CHEMBL3601190; SCHEMBL16481787; BDBM50107893

BI-1408; SCHEMBL22151087; BDBM50272886; HY-112282; CS-0044696

CHEMBL1761523; SCHEMBL3132633; BDBM50340411

CHEMBL3921669; SCHEMBL16085284; BDBM251580; US9453031, 3

CHEMBL3623824; SCHEMBL15311560; BDBM191880; US9187429, 5; US9187429, 6; US9187429, 7; N-(4-(4-Cyanophenyl)-5,6,7,8-tetrahydroisoquinoline-8-yl)propanamide; (rac)-N-(4-(4-Cyanophenyl)-5,6,7,8-tetrahydroisoquinolin-8-yl)propionamide

CHEMBL2041178; BDBM50385791

CHEMBL371409; BDBM50171282

CHEMBL1777861; BDBM50344068

CHEMBL453167; BDBM50260761

CHEMBL2043326; SCHEMBL2120049; BDBM50385820

CHEMBL2347410; SCHEMBL14751494

CHEMBL3973040; SCHEMBL17492337; BDBM253995; US9481673, (S)-5

CHEMBL330425; SCHEMBL5347277; BDBM50146654

CHEMBL4079801; BDBM50264807

CHEMBL4066339; SCHEMBL10146409; BDBM50264806

CHEMBL2419501; SCHEMBL3223721; BDBM50439281; ZINC34846050; ethyl 6-[3-(benzylsulfonylcarbamoyl)azetidin-1-yl]-5-cyano-2-methylpyridine-3-carboxylate; 5-Cyano-2-methyl-6 (3-phenylmethanesulfonylaminocarbonyl-azetidin-1-yl)-nicotinic acid ethyl ester; 5-Cyano-2-methyl-6-(3-phenylmethanesulfonylaminocarbonyl-azetidin-1-yl)-nicotinic acid ethyl ester

Methoxybemitil; CHEMBL2018906; Methoxybemithyl; 2-ethylsulfanyl-6-methoxy-1H-benzimidazole; 1H-Benzimidazole, 2-(ethylthio)-6-methoxy-; SCHEMBL13651209; CTK8D7266; DTXSID20914099; ZINC9187549; BDBM50380518; STL164078; AKOS000423048; AKOS005363656; MCULE-3849567164; CS-0117859; 2-(ethylsulfanyl)-6-methoxy-1H-1,3-benzodiazole; 2-(Ethylsulfanyl)-1h-benzimidazol-5-yl methyl ether; Z16077930; 2-(ETHYLSULFANYL)-5-METHOXY-1H-1,3-BENZODIAZOLE

CHEMBL3623823; SCHEMBL15312033; BDBM191882; US9187429, 8; N-[4-(4-cyanophenyl)-5,6,7,8-tetrahydroisoquinolin-8-yl]acetamide; (rac)-N-(4-(4-Cyanophenyl)-5,6,7,8-tetrahydroisoquinolin-8-yl)acetamide

CHEMBL3261485; SCHEMBL1077301; BDBM50014554

CHEMBL2041191; BDBM50385804

CHEMBL2041010; BDBM50385826

CHEMBL2385904; SCHEMBL3094364; BDBM50434982

CHEMBL497031; SCHEMBL1379627; BDBM50269055; ZINC40428795; (4,4-difluoropiperidin-1-yl)-[1-propan-2-yl-5-(1-propan-2-ylpiperidin-4-yl)oxyindol-2-yl]methanone; (4,4-Difluoropiperidin-1-yl)[1-isopropyl-5-(1-isopropylpiperidin-4-yloxy)-1H-indol-2-yl]methanone

RG7834; 2072057-17-9 (S-isomer); RG7834 S-isomer; SCHEMBL16942404; EX-A3683; BDBM50467761; MFCD31555773; ZINC584641403; HY-117650A; RG 7834; CS-0084529; RG7834 (RO 7020322)

CHEMBL3896543; SCHEMBL17492273; BDBM253996; US9481673, (S)-6

CHEMBL518287; SCHEMBL2010076; BDBM50263678; N-[2-[[(3-chlorophenyl)-phenylmethyl]amino]-2-oxoethyl]-4-fluorobenzamide; rac-n-({[(3-chloro-phenyl)-phenyl-methyl]-carbamoyl}-methyl)-4-fluoro-benzamide

CHEMBL4076061

CHEMBL4069245; SCHEMBL17723589; BDBM50249183

DWK-1339; UNII-WN8TEM4Q1F; MDR-1339; WN8TEM4Q1F; CHEMBL4066961; SNU-0039; 2-(3,4-dimethoxyphenyl)-5-(3-methoxypropyl) benzofuran; Benzofuran, 2-(3,4-dimethoxyphenyl)-5-(3-methoxypropyl)-; SCHEMBL3002082; BCP34010; EX-A1942; BDBM50250939; ZB1549; HY-14503; CS-0003407; Q27292735; 2-(3,4-dimethoxyphenyl)-5-(3-methoxypropyl)-1-benzofuran

CHEMBL478036; BDBM50263681; N-{[(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylmethyl)-carbamoyl]-methyl}-4-fluoro-benzamide

CHEMBL2348851; SCHEMBL2272089; BDBM50431392

CHEMBL2041181; SCHEMBL2119681; BDBM50385794

CHEMBL1643789; BDBM50333850

BI-7273; CHEMBL3823478; BI7273; GTPL9146; SCHEMBL19869878; EX-A990; BCP17545; BDBM50183448; MFCD30489736; s8179; ZINC575448880; CCG-268068; CS-5887; HY-100351; J3.533.936A; A16068; Q27075221

CHEMBL2043169; BDBM50385814

CHEMBL3084761

CHEMBL3398252; SCHEMBL15287472; BDBM50103451

CHEMBL2331699; SCHEMBL13727574; BDBM50428331; 9-fluoro-7-(5-fluoropyridin-3-yl)-1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline

CHEMBL4061793; SCHEMBL16760693; HY-101789; CS-0021899

CHEMBL1668261; FXR_68; BDBM225975; BDBM50336388

SCHEMBL117858; CHEMBL3664711; BDBM107657; US8575157, 32

CHEMBL3928571; SCHEMBL17492321; BDBM253998; US9481673, (S)-8

CHEMBL3622445

XAV-939; XAV939; XAV 939; C14H11F3N2OS; CHEMBL1086580; 2-(4-(trifluoromethyl)phenyl)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-4-ol; MFCD16879017; 2-[4-(trifluoromethyl)phenyl]-7,8-dihydro-5H-thiino[4,3-d]pyrimidin-4-ol; 2-[4-(Trifluoromethyl)phenyl]-7,8-Dihydro-5h-Thiopyrano[4,3-D]pyrimidin-4-Ol; NVP-XAV-939; NVP-XAV 939; Maybridge3_005018; cc-343; MLS006012021; SCHEMBL7783488; TB3748-GMP; SCHEMBL15315468; AOB4150; DTXSID60369423; XAV939,XAV-939; BCPP000009; HMS1445E02; HMS3414D07; HMS3648B17; HMS3654O16; HMS3678D07; HMS3743E05; BCP02128; EX-A1760; ABP000288; BDBM50188594; BDBM50318567; s1180; ZINC13467799; AKOS015954858; AKOS024457786; AKOS026750243; CCG-208105; CS-0494; MCULE-6143908878; SB19432; IDI1_016405; KS-0000181U; NCGC00250397-01; NCGC00484998-01; AC-28393; AK198691; CS-10386; HY-15147; SC-95571; SMR003874205; XAV 939/XAV939,NVP-XAV939; XAV939, >=98% (HPLC); DB-067924; FT-0675873; SW218311-2; X7558; A25698; W-5666; SR-01000946403; J-511234; SR-01000946403-1; BRD-K12762134-001-01-3; BRD-K12762134-001-05-4; Q27132250; 6,8-Dihydro-2-[4-(trifluoromethyl)phenyl]-5H-thiopyrano[3,4-d]pyrimidine; 2-(4-(Trifluoromethyl)phenyl)-7,8-dihydro-5H-thiopyrano-[4,3-d]pyrimidin-4-ol; 2-[4-(trifluoromethyl)phenyl]-1H,4H,5H,7H,8H-thiopyrano[4,3-d]pyrimidin-4-one

CHEMBL1777855; BDBM50344080

UNII-CJ67MDQ7KO; CJ67MDQ7KO; MK-3168; CHEMBL2386571; SCHEMBL2681510; CHEMBL2386558; BDBM50434313; ZINC68247237

CHEMBL2436225; SCHEMBL15621759

CHEMBL4093930; SCHEMBL696868; BDBM50269417

CHEMBL3956933; SCHEMBL17492279; BDBM254006; US9481673, (S)-16

CHEMBL4093444; SCHEMBL18893754; BDBM50263623

SCHEMBL959530; CHEMBL3645517; BDBM107478; US8592410, 18

CHEMBL3937744; SCHEMBL16290685; BDBM217819; US9212182, 685

SCHEMBL2896906; CHEMBL3612810; BDBM155928; US9018211, 52

CHEMBL3359019; SCHEMBL17454182; SCHEMBL17454184; BDBM50026256

CHEMBL514198; BDBM50263400

CHEMBL3785768; BDBM50160712

SCHEMBL116078; CHEMBL3664646; BDBM107588; US8575157, 26

SCHEMBL1542257; CHEMBL2431460

CHEMBL3936446; SCHEMBL14940271; BDBM183977; US9150566, 14

CHEMBL2347993; SCHEMBL14751472; BDBM50431368

SCHEMBL119315; CHEMBL3664651; BDBM107594; US8575157, 40

CHEMBL1272016; BDBM50329725

BDBM50453431

Lp-PLA2-IN-2; CHEMBL3922315; GTPL9796; BDBM50197673; HY-133148; CS-0112331; J3.616.652E; (S)-23 [PMID: 27933945]

CHEMBL3931654; SCHEMBL16766914; BDBM184072; US9150566, 110

CHEMBL294616; BDBM50001683

CHEMBL4082198; SCHEMBL696678; BDBM50269427

CHEMBL3091536; SCHEMBL4026798; UDA-680; BDBM50443871

CHEMBL2017112; SCHEMBL10202743; BDBM50380996

CHEMBL3774855; SCHEMBL17761865; SCHEMBL17762388; BDBM50153594; J3.591.555I

CHEMBL2407954; SCHEMBL10240955

CHEMBL4064672; RO6889678; SCHEMBL15508072; SCHEMBL17874012; BDBM50237769

CHEMBL2041171; BDBM50385784

CHEMBL2436223; SCHEMBL15621804

CHEMBL3805400

SCHEMBL116926; CHEMBL3664661; BDBM107605; US8575157, 54

CHEMBL3427276; BDBM50088180

CHEMBL3979498; SCHEMBL16306330; BDBM217696; US9212182, 672

CHEMBL566683; SCHEMBL9910177; BDBM50302899

CHEMBL452423; SCHEMBL2008516; BDBM50263627; N-[2-[[(4-chlorophenyl)-phenylmethyl]amino]-2-oxoethyl]pyridine-4-carboxamide; rac-n-({[(4-chloro-phenyl)-phenyl-methyl]-carbamoyl}-methyl)-isonicotinamide

CHEMBL2043172; BDBM50385817

CHEMBL3913644; SCHEMBL14939966; BDBM184013; US9150566, 50

CHEMBL391070; SCHEMBL3556867; BDBM50209925

CHEMBL2041179; BDBM50385792

CHEMBL1808640; SCHEMBL3167880; SCHEMBL3167895; BDBM50349500

CHEMBL3622437; SCHEMBL13724649

CHEMBL429585; SCHEMBL4549006; BDBM50376019

CHEMBL1668240; BDBM50336385

CHEMBL3941588; SCHEMBL14916322; BDBM50197094; Q27455848; 6-chloro-4-phenyl-2-piperidin-1-ylquinoline-3-carboxylic acid

CHEMBL4102132

CHEMBL3890222; SCHEMBL14940484; BDBM183996; US9150566, 33

CHEMBL3627895; SCHEMBL17835156; BDBM50125974

CHEMBL1643783; BDBM50333844

CHEMBL2018903; BDBM50380520; J3.516.540A

CHEMBL1761530; SCHEMBL3040233; BDBM50340414

CHEMBL3980898; BDBM50207061

CCT128930; CCT-128930; CCT 128930; CHEMBL263664; 4-[(4-chlorophenyl)methyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-amine; C18H20ClN5; 4-[(4-chlorophenyl)methyl]-1-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}piperidin-4-amine; cc-512; MLS006010998; SCHEMBL1002126; DTXSID80590818; HMS3656J07; HMS3750O13; BCP02903; BDBM50237622; MFCD13177916; s2635; ZINC16052630; AKOS025395962; AM86141; BCP9000496; CCG-267939; CS-0473; SB19264; 4-((4-chlorophenyl)methyl)-1-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-4-piperidinamine; NCGC00346621-01; NCGC00346621-02; NCGC00346621-05; AC-32074; HY-13260; SMR004702796; BCP0726000272; SW218209-2; X7446; L-1965; US8796293, 17; J-513161; 4-(4-Chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-; 4-(4-Chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-ylamine

CHEMBL2386077; SCHEMBL3090455; BDBM50434988

CHEMBL4093284; SCHEMBL14970620; BDBM50232621

CHEMBL4095848; SCHEMBL697799; BDBM50269443

CHEMBL1819090; SCHEMBL162310; BDBM50351402

TCMDC-139046; CHEMBL586213; BDBM50396034

CHEMBL3287548; BDBM50019934; 5-[3-(4-chlorophenoxy)propyl]-8-fluoro-1,2,3,4-tetrahydropyrido[4,3-b]indole

4-({2-[(5-cyano-1,3-thiazol-2-yl)amino]pyridin-4-yl}methyl)-N-methylpiperazine-1-carboxamide; N-(1,3-Thiazol-2-yl)pyridin-2-amine 20; BDBM5290; CHEMBL375248; SCHEMBL5742011; 4-[2-(5-cyanothiazol-2-ylamino)pyridin-4-ylmethyl]piperazine-1-carboxylic acid methylamide; N-Methyl-4-[2-[(5-cyano-2-thiazolyl)amino]-4-pyridylmethyl]piperazine-1-carboxamide

CHEMBL2018909; BDBM50380523

CHEMBL3235253; SCHEMBL14906011; BDBM50000985

CHEMBL3084778

CHEMBL2436221; SCHEMBL15621720

CHEMBL3414926; BDBM50078374; Q27454407

CHEMBL3957752; SCHEMBL14940305; BDBM183987; US9150566, 24

CCT241736; CHEMBL2207503; SCHEMBL17092840; BDBM247371; BCP29563; EX-A1838; BDBM50401421; HY-18161; CCT 241736 pound>>CCT-241736; CS-0007372; US9447092, 1

CHEMBL3806029

BDBM50366405

SCHEMBL2575074; BDBM50453434

CHEMBL3601185; SCHEMBL17194054; BDBM50107848

CHEMBL4074586; SCHEMBL696866; BDBM50269431

CHEMBL3949677; SCHEMBL2188869; BDBM50196833; J3.563.105D

CHEMBL204772; BDBM22028; Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione, 36

CHEMBL3091531; SCHEMBL88036; BDBM50443881

CHEMBL1808624; SCHEMBL3183338; BDBM50349484

CHEMBL2010880; BDBM50379681

CHEMBL3313969; 9-fluoro-1-methyl-7-(4-methylpyridin-3-yl)-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline; SCHEMBL15463725; BDBM50044143

CHEMBL2041170; SCHEMBL2120298; BDBM50385783

CHEMBL2431365; SCHEMBL1542606; BDBM50441245

CHEMBL2041180; SCHEMBL2119928; BDBM50385793

CHEMBL4102181; BDBM50261310

CHEMBL3967713; SCHEMBL17492284; BDBM253997; US9481673, (S)-7

CHEMBL2017106; SCHEMBL556539; BDBM50380976

CHEMBL1761531; BDBM50340415

CHEMBL2041176; BDBM50385789

CHEMBL2041189; BDBM50385802

CHEMBL2041168; SCHEMBL2120225; BDBM50385781

CHEMBL3948499; SCHEMBL14941571; BDBM184136; US9150566, 174

CHEMBL1221429; SCHEMBL4023655; BDBM50325063; 4-[(1-benzyltetrazol-5-yl)-(4-cyclobutyl-1,4-diazepan-1-yl)methyl]-N-methylbenzamide

SIRT-IN-1; CHEMBL2332055; SCHEMBL16014053; EX-A3489; BDBM50431096; ZINC95587718; DA-21542; HY-16615; CS-0009171; FT-0755224; Q27452272; 4-(4-(2-pivalamidoethyl)piperidin-1-yl)thieno[3,2-d]pyrimidine-6-carboxamide; 4-[4-[2-(Pivaloylamino)ethyl]piperidino]thieno[3,2-d]pyrimidine-6-carboxamide

CHEMBL3956563; BDBM217422; US9212182, 419; US9212182, 420

CHEMBL2041193; SCHEMBL2121755; BDBM50385806

CHEMBL4076186; BDBM50269447

CHEMBL3359523; SCHEMBL2018583; BDBM50041983

CHEMBL3233058; SCHEMBL15091041; BDBM50007038; 6-[[(1R,2S)-2-aminocyclohexyl]amino]-4-[(6-methylpyridin-2-yl)amino]pyridazine-3-carboxamide

CHEMBL2347991; SCHEMBL14737227; BDBM50431370

CHEMBL476762; SCHEMBL2009811; BDBM50263395; AKOS006514857; N-[2-[[(4-chlorophenyl)-phenylmethyl]amino]-2-oxoethyl]-2-phenylacetamide; rac-n-({[(4-chloro-phenyl)-phenyl-methyl]-carbamoyl}-methyl)-2-phenyl-acetamide

RO5256390; (S)-4-((S)-2-Phenyl-butyl)-4,5-dihydro-oxazol-2-ylamine; SCHEMBL503518; CHEMBL3684869; BDBM109524; ZINC113978348; HY-12700; CS-0012279; RO5256390, >=98% (HPLC); US8604061, 292; (4S)-4-[(2S)-2-phenylbutyl]-4,5-dihydro-1,3-oxazol-2-amine

CHEMBL3125270; BDBM50448866

CHEMBL2348853; SCHEMBL14737096; BDBM50431390; N-tert-butyl-2-(6-chloro-1-methyl-1H-indazol-3-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide

CHEMBL3971182; SCHEMBL14917069; BDBM50197086; 6,8-Dichloro-4-phenyl-2-piperidin-1-yl-quinoline-3-carboxylic acid; 6,8-dichloro-4-phenyl-2-piperidin-1-ylquinoline-3-carboxylic acid

SCHEMBL589124; CHEMBL3664683; BDBM107627; US8575157, 79

SCHEMBL18288802; BDBM50458024

CHEMBL3627897; SCHEMBL17825842; BDBM50125977

UNII-884KT10YB7; 884KT10YB7; Achedos; Duractin; Istomar; Quicran; Radinat; Ranisen; Raniter; Ulceranin; Urantac; Verlost; Vizerul; Weichilin; Xanidine; Zantadin; Acidex; Atural; Axoban; Ezopta; Logast; Mauran; Randin; Sampep; Vesyca; Weidos; Zantab; Ranin; Ratic; Ul-Pep; Ranitidinum [INN-Latin]; Ranitidina [INN-Spanish]; HSDB 3925; Major ranitidine; Spectrum_001141; Up and up acod redicer; Topcare jeartburn relief; Prestwick0_000201; Prestwick1_000201; Spectrum2_001425; Spectrum3_000909; Spectrum4_001008; SCHEMBL825; KBioGR_001475; KBioSS_001621; DivK1c_000440; Ranitidine [USAN:INN:BAN]; SPBio_001530; SPBio_002102; CHEMBL1790041; DTXSID8045191; KBio1_000440; KBio2_001621; KBio2_004189; KBio2_006757; KBio3_001858; NINDS_000440; EINECS 266-332-5; BDBM50103506; AKOS030228563; DB00863; MCULE-2682233624; KS-0000111Y; DB-054918; FT-0630765; FT-0653261; EC 266-332-5; Q423037

CHEMBL2331704; SCHEMBL15463838; BDBM50428336

CHEMBL3911035; SCHEMBL17492274; BDBM253992; US9481673, (S)-2

CHEMBL2048492; SCHEMBL2579264; BDBM50386882

CHEMBL2347990; BDBM50431402

CHEMBL4087688; SCHEMBL10146406; BDBM50264821

CHEMBL2048490; SCHEMBL2577306; BDBM50386881

CHEMBL2386075; SCHEMBL3091367; BDBM50434983

CHEMBL1089270; BDBM50314388

CHEMBL3899527; BDBM50197676

CHEMBL566242; SCHEMBL9910189; BDBM50302902

SCHEMBL736524; CHEMBL3664687; BDBM107631; US8575157, 83

CHEMBL2041164; BDBM50385778

CHEMBL3981054; SCHEMBL17492316; BDBM253993; US9481673, (S)-3

CHEMBL2018922; Oprea1_174290; SCHEMBL1065421; ZINC3848073; BDBM50380533; AKOS000101026; ST049297

CHEMBL4063121; SCHEMBL956633; BDBM50253397

CHEMBL3939766; SCHEMBL14939830; BDBM184118; US9150566, 156

CHEMBL1761532; SCHEMBL3037835; BDBM50340416

BDBM50453432

GNF-Pf-5341; Astemisinin; Artemisinin,(S); NSC-369397; Artemisinin, 18; SCHEMBL60303; CHEMBL567597; BDBM36349; CID452191; AKOS015894973; ZINC100014791; N1827

CHEMBL2147070

CHEMBL1761525; SCHEMBL3040455; BDBM50340413

CHEMBL3949600; SCHEMBL16305915; BDBM217435; US9212182, 323; US9212182, 324

CHEMBL2016639; ZINC2626372; BDBM50380604; AKOS007963767; MCULE-5549066893

CHEMBL2163365; SCHEMBL14969065; BDBM50395799; Q27451524

SCHEMBL118290; CHEMBL3664681; BDBM107625; US8575157, 77

CHEMBL3237564; SCHEMBL15091013; BDBM50007093

CHEMBL3935923; SCHEMBL17492280; BDBM254002; US9481673, (S)-12

CHEMBL3922000; CHEMBL3933704; SCHEMBL1118763; SCHEMBL6519634; SCHEMBL12786478; BDBM50235370; BDBM50235371

CHEMBL2018910; BDBM50380524

CHEMBL2386076; SCHEMBL3073307; BDBM50434986

SCHEMBL118014; CHEMBL3664712; BDBM107658; US8575157, 33

CHEMBL3091547; SCHEMBL4024980; BDBM50443883

BDBM50451565

CHEMBL3905467; SCHEMBL17492325; BDBM253994; US9481673, (S)-4

SCHEMBL116872; CHEMBL3664718; BDBM107665; US8575157, 59

CHEMBL495331; SCHEMBL1150565; BDBM25335; L-900525

CHEMBL4075203; SCHEMBL10147223; BDBM50264803

CHEMBL516125; SCHEMBL2011567; BDBM50263403; 4-fluoro-N-[2-oxo-2-[[phenyl(pyridazin-3-yl)methyl]amino]ethyl]benzamide; rac-4-fluoro-n-{[(phenyl-pyridazin-3-yl-methyl)-carbamoyl]-methyl}-benzamide

CHEMBL3627899; SCHEMBL17825634; BDBM50125979

BDBM50451568

TMC207; Sirturo; TMC-207; R207910; TMC 207; R 207910; UNII-78846I289Y; R-207910; 843663-66-1 (free base); MMV689758; 78846I289Y; AIDS-222089; Bedaquiline [USAN:INN]; bedaquilina; bedaquilinum; HSDB 8217; AIDS 222089; Tube401; Bedaquiline (USAN/INN); AR)-Bedaquiline; Bedaquiline (TMC-207); C32H31BrN2O2; SCHEMBL295482; CHEMBL376488; GTPL11171; DTXSID80903989; AOB87357; EX-A4133; ZINC4655029; BDBM50063995; s5623; AKOS022186476; ACN-040787; CCG-270030; DB08903; compound 1a [PMID: 17496888]; KS-0000002K; NCGC00348215-01; NCGC00348215-03; NCGC00348215-04; AC-28385; HY-14881; A12327; D09872; J-500265; Q1257318; R403323; TMC207; R207910

AZ7371; TBA-7371; UNII-R3T98GBE3C; R3T98GBE3C; CHEMBL3109802; ZA7371; AZ-7371DprE1-IN-1; AZ7371;DprE1-IN-1; SCHEMBL16395186; EX-A777; BCP16818; BDBM50019654; MFCD29477419; ZINC103248024; AZ-7371; CS-5414; ZA-7371; HY-19750; FT-0700212; J-690193

CHEMBL3291354; SCHEMBL4371142; BDBM50018802; (4s,7r)-2-(2-chloro-phenyl)-1,7,8,8-tetramethyl-1,2,4,5,6,7-hexahydro-4,7-methano-indazol-3-one

CHEMBL3983937; SCHEMBL17712767; BDBM50192034

CHEMBL2041167; BDBM50385829

CHEMBL3091464; SCHEMBL4025822; BDBM50443878

CHEMBL2043170; BDBM50385815

CHEMBL3968947; BDBM50203654

CHEMBL476360; SCHEMBL2007032; BDBM50263628; rac-thiophene-3-carboxylic acid ({[(4-chloro-phenyl)-phenyl-methyl]-carbamoyl}-methyl)-amide

CHEMBL4081789; BDBM50266625

CHEMBL3964719; SCHEMBL14939808; BDBM183964; US9150566, 1

CHEMBL566685; SCHEMBL2698537; BDBM50302905; Q27074437

CHEMBL1170367; BDBM50321518; N-(7-(N-ethylacetamido)-4-methoxybenzo[d]thiazol-2-yl)-1-methyl-1H-pyrazole-5-carboxamide

CHEMBL565843; SCHEMBL9910190; BDBM50302903

CHEMBL3695718; SCHEMBL10086291; BDBM147139; US8957077, 1-9

SCHEMBL117100; CHEMBL3664684; BDBM107628; US8575157, 80

BI-9564; BI 9564; CHEMBL3823101; GTPL8950; SCHEMBL19869872; BCP17135; EX-A1652; BDBM50183449; BI9564; s8113; AKOS027470219; ZINC526061652; CCG-268067; CS-5888; AK685542; BP-25349; BS-15735; DS-001715; HY-100352; BI-9564, >=97% (HPLC); J3.600.898I; Q27075224

CHEMBL4105361; BDBM50264796

CHEMBL490609; BDBM50263726

CHEMBL1258308; SCHEMBL2971194; BDBM50327480; 8-[3-((R)-2-Methyl-pyrrolidin-1-yl)-propoxy]-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one; 8-[3-[(2R)-2-methylpyrrolidin-1-yl]propoxy]-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one

CHEMBL2207500; SCHEMBL17092838; BDBM247369; BDBM50401434; US9447092, 2

CHEMBL1766811; CHEMBL1766812; SCHEMBL594863; SCHEMBL1101806; SCHEMBL1102060; BDBM50341782; BDBM50341783

CHEMBL3959018; SCHEMBL14916231; BDBM50197093; 6-chloro-4-phenyl-2-piperidin-1-yl-3-(2H-tetrazol-5-yl)quinoline; 65X

CHEMBL3719193; SCHEMBL696011; BDBM50269426

CHEMBL3427277; SCHEMBL18191219; BDBM50088181

CHEMBL234412; BDBM50209938; B2Q

CHEMBL2380648; SCHEMBL19248200; SCHEMBL20456976; BDBM50433411; Q27451826

CHEMBL3917412; SCHEMBL14940542; BDBM183997; US9150566, 34

CHEMBL321051; BDBM50106747; N-(4-hexylphenyl)-N''-hydroxyimidoformamide

CHEMBL1778524; SCHEMBL2188929; BDBM50344164

CHEMBL4087402; BDBM50269455

CHEMBL3893614; SCHEMBL14809707; BDBM50206961

CHEMBL476568; N-(2-(benzhydrylamino)-2-oxoethyl)-4-fluorobenzamide; N-[2-(benzhydrylamino)-2-oxoethyl]-4-fluorobenzamide; SCHEMBL2010308; BDBM50263631; ZINC16636899; AKOS016883463; MCULE-2505051243; N-[(Benzhydryl-carbamoyl)-methyl]-4-fluoro-benzamide; Z68358697

CHEMBL2041172; BDBM50385785

CHEMBL1808643; SCHEMBL3185006; SCHEMBL3185020; BDBM50349503

CHEMBL3964219; SCHEMBL17492286; BDBM253999; US9481673, (S)-9

CHEMBL3623825; SCHEMBL15312196; BDBM191883; US9187429, 9; N-(4-(4-Cyanophenyl)-5,6,7,8-tetrahydroisoquinoline-8-yl)-2-methylpropanamide; N-[4-(4-cyanophenyl)-5,6,7,8-tetrahydroisoquinolin-8-yl]-2-methylpropanamide

CHEMBL1258079; BDBM50327479

CHEMBL2048485; SCHEMBL2577687; BDBM50386878; (1S,2R,3R,4R,6S)-4-(hydroxymethyl)-6-[3-[(4-methoxyphenyl)methyl]phenyl]cyclohexane-1,2,3-triol

CHEMBL3954973; SCHEMBL14940209; BDBM184016; US9150566, 53

CHEMBL3627896; SCHEMBL19813674; BDBM50125976

SCHEMBL641367; CHEMBL3786799

CHEMBL2041185; BDBM50385830

CHEMBL4064441; SCHEMBL957623; BDBM50253339

BI-135585; UNII-DA4HT8614K; DA4HT8614K; SCHEMBL117891; CHEMBL3664717; BDBM107664; US8575157, 48; Q27276296

CHEMBL3261482; SCHEMBL1078926; BDBM50014551

CHEMBL3091529; SCHEMBL4025571; BDBM50443882

CHEMBL1257851; SCHEMBL2982400; BDBM50327485; (R)-8-(1-Isopropyl-piperidin-4-yloxy)-4-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one; (4R)-4-methyl-8-(1-propan-2-ylpiperidin-4-yl)oxy-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one

CHEMBL4282052; BDBM50468128; HY-114191A; CS-0081939

CHEMBL3291430; SCHEMBL16395051; BDBM50019659

CHEMBL478035; BDBM50263680

CHEMBL3941727; SCHEMBL16290657; BDBM217758; US9212182, 696

CHEMBL1257376; SCHEMBL2980351; BDBM50327483; 2-(4-Fluoro-benzyl)-8-(1-isopropyl-piperidin-4-yloxy)-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one; 2-[(4-fluorophenyl)methyl]-8-(1-propan-2-ylpiperidin-4-yl)oxy-3,4-dihydropyrazino[1,2-a]indol-1-one

CHEMBL3937108; SCHEMBL14940043; BDBM184074; US9150566, 112

CHEMBL3353863; SCHEMBL9892065; BDBM50042590

CHEMBL1824230; CHEMBL1824231; SCHEMBL4083753; SCHEMBL4083759; SCHEMBL4084270; CHEMBL1822862; SCHEMBL12050659; BDBM50352081; BDBM50352099; N,N-dimethyl-4-[4-(3-piperidin-1-ylpropoxy)phenyl]cyclohexan-1-amine

CHEMBL3974300; SCHEMBL17492300; BDBM254005; US9481673, (S)-15

CHEMBL1258873; SCHEMBL2980067; BDBM50327482; 2-methyl-8-(1-propan-2-ylpiperidin-4-yl)oxy-3,4-dihydropyrazino[1,2-a]indol-1-one; 8-(1-Isopropyl-piperidin-4-yloxy)-2-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one

CHEMBL2043168; SCHEMBL2119741; BDBM50385813

CHEMBL2207501; SCHEMBL17092832; BDBM247370; BDBM50401429; US9447092, 3

CHEMBL2041183; SCHEMBL2120998; BDBM50385797

CHEMBL3259928; SCHEMBL3019971; BDBM50011135

CHEMBL3623830; SCHEMBL15313271; BDBM50125049

BDBM50366400

CHEMBL3895473; SCHEMBL17492306; BDBM253991; US9481673, (S)-1